Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ortho Clinical Diagnostics
Raritan, New Jersey, United Statesquidelortho.com ↗
- Ownership
- Public · QDEL
- Employees
- ~4200
- Development stage
- Commercial
01
Overview
Ortho Clinical Diagnostics was a global leader in in vitro diagnostic solutions for hospitals, laboratories, and blood banks. The company developed automated systems and assays for immunohematology and clinical chemistry. Its innovations include the first FDA-approved automated random access hepatitis tests and early high-volume COVID‑19 antibody/antigen tests. Its products are widely used worldwide to improve efficiency and accuracy in laboratory medicine.
- Therapeutic areas
- OtherInfectious DiseasesCardiovascularHematology
- Modalities
- DeviceDiagnostic reagentImmunoassayMolecular diagnostics system
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Ortho Clinical Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ortho Clinical Diagnostics.